{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P09429",
      "entity_text" : "HMGB1",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Hayakawa et al used multiple doses of HMGB1 and showed biphasic effects on proliferation, where low levels of HMGB1 (1-10 ng/ml) increased the proliferation rates of EPCs, but higher concentrations (100-1,000 ng/ml) appeared to have no effect, suggesting that high concentrations of HMGB1 may be deleterious by promoting endothelial inflammation and inducing neurotoxicity.",
  "reading_complete" : "2020-08-02T10:58:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:56:53Z",
  "trigger" : "increased",
  "evidence" : [ "HMGB1 (1-10 ng/ml) increased the proliferation" ],
  "pmc_id" : "4121357",
  "score" : 0
}